References
- Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3:20–31.
- Ruiz-Maldonado R, Orozco-Covarrubias ML. Postinflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg. 1997;16:36–43. doi:10.1016/s1085-5629(97)80034-x
- Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. Am J Clin Dermatol. 2018;19:489–503. doi:10.1007/s40257-017-0333-6
- Elbuluk N, Grimes P, Chien A, et al. The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation. Am J Clin Dermatol. 2021;22:829–836. doi:10.1007/s40257-021-00633-4
- Silpa-Archa N, Kohli I, Chaowattanapanit S, et al. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017;77:591–605. doi:10.1016/j.jaad.2017.01.035
- Shenoy A, Madan R. Post-inflammatory hyperpigmentation: a review of treatment strategies. J Drugs Dermatol. 2020;19:763–768. doi:10.36849/JDD.2020.4887
- Grimes PE. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg. 2009;28:77–85. doi:10.1016/j.sder.2009.04.001
- Tomita Y, Maeda K, Tagami H. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. Pigment Cell Res. 1992;5:357–361. doi:10.1111/j.1600-0749.1992.tb00562.x
- Taylor SC, Grimes PE, Lim J, et al. Postinflammatory hyperpigmentation. J Cutan Med Surg. 2009;13:183–191. doi:10.2310/7750.2009.08077
- Park JY, Park JH, Kim SJ, et al. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal. J Cutan Pathol. 2017;44:118–124. doi:10.1111/cup.12849
- Lacz NL, Vafaie J, Kihiczac NI, et al. Postinflammatory hyperpigmentation: a common but troubling condition. Int J Dermatol. 2004;4:362–365. doi:10.1111/j.1365-4632.2004.02267.x
- Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80:387–394.
- Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol. 2002;46(2 Suppl):S98–S106. doi:10.1067/mjd.2002.120791
- Dunwell P, Rose A. Study of the skin disease spectrum occurring in an Afro-Caribbean population. Int J Dermatol. 2003;42:287–289. doi:10.1046/j.1365-4362.2003.01358.x
- Chua-Ty G, Goh CL, Koh SL. Pattern of skin diseases at the national skin centre (Singapore) from 1989–1990. Int J Dermatol. 1992;31:555–559. doi:10.1111/j.1365-4362.1992.tb02717.x
- Klopot A, Baida G, Kel A, et al. Transcriptome analysis reveals intrinsic proinflammatory signaling in healthy African American skin. J Invest Dermatol. 2022;142:1360–1371. doi:10.1016/j.jid.2021.09.031
- Wolf ST, Jablonski NG, Ferguson SB, et al. Four weeks of vitamin D supplementation improves nitric oxide-mediated microvascular function in college-aged African Americans. Am J Physiol Heart Circ Physiol. 2020;319:H906–H914. doi:10.1152/ajpheart.00631.2020
- Hurr C, Patik JC, Kim K, et al. Tempol augments the blunted cutaneous microvascular thermal reactivity in healthy young African Americans. Exp Physiol. 2018;103:343–349. doi:10.1113/EP086776
- Kim K, Hurr C, Patik JC, Matthew Brothers R. Attenuated cutaneous microvascular function in healthy young African Americans: role of intradermal L-arginine supplementation. Microvasc Res. 2018;118:1–6. doi:10.1016/j.mvr.2018.02.001
- Stowe RP, Peek MK, Cutchin MP, Goodwin JS. Plasma cytokine levels in a population-based study: relation to age and ethnicity. J Gerontol a Biol Sci Med Sci. 2010;65A:429–433. doi:10.1093/gerona/glp198
- Ho RC, Davy KP, Hickey MS, Melby C. Circulating tumor necrosis factor alpha is higher in non-obese, non-diabetic Mexican Americans compared to non-Hispanic white adults. Cytokine. 2005;30:14–21. doi:10.1016/j.cyto.2004.10.015
- Mayr FB, Spiel AO, Leitner JM, et al. Ethnic differences in plasma levels of interleukin-8 (Il-8) and granulocyte colony stimulating factor (G-CSF). Transl Res. 2007;149:10–14. doi:10.1016/j.trsl.2006.06.003
- Coe CL, Love GD, Karasawa M, et al. Population differences in proinflammatory biology: Japanese have healthier profiles than Americans. Brain Behav Immun. 2001;25(3):494–502. doi:10.1016/j.bbi.2010.11.013
- Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–1830. doi:10.1172/JCI19451
- Yamashita A, Soga Y, Iwamoto Y, et al. Macrophage-adipocyte interaction: marked interleukin-6 production by lipopolysaccharide. Obesity. 2007;15:2549–2552. doi:10.1038/oby.2007.305
- Czarnowicki T, He H, Krueger JG, Guttman-Yassky E. Atopic dermatitis endotypes and implications for targeted therapeutics. J Allergy Clin Immunol. 2019;143:1–11. doi:10.1016/j.jaci.2018.10.032
- Wongvibulsin S, Sutaria N, Kannan S, et al. Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17‑centered cutaneous immune activation. Sci Rep. 2021;11:11175. doi:10.1038/s41598-021-90105-w
- Park HR, Min SK. Expression of S100A2 and S100B proteins in epithelial tumors of the skin. J Cutan Pathol. 2003;30:373–378. doi:10.1034/j.1600-0560.2003.00081.x
- Grayson C, Heath CR. Dupilumab improves atopic dermatitis and post-inflammatory hyperpigmentation in patient with skin of color. J Drugs Dermatol. 2020;19:776–778. doi:10.36849/JDD.2020.4937
- Callender VD. Considerations for treating acne in ethnic skin. Cutis. 2005;76(2 Suppl):19–23.
- Girardeau S, Mine S, Pageon H, Asselineau D. The Caucasian and African skin types differ morphologically and functionally in their dermal component. Exp Dermatol. 2009;18:704–711. doi:10.1111/j.1600-0625.2009.00843.x
- Girardeau-Hubert S, Deneuville C, Pageon H, et al. Reconstructed skin models revealed unexpected differences in epidermal African and Caucasian skin. Sci Rep. 2019;9:7456. doi:10.1038/s41598-019-43128-3
- Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. The keloid disorder: heterogeneity, histopathology, mechanisms and models. Front Cell Dev Biol. 2020;8:360. doi:10.3389/fcell.2020.00360
- Wolfram D, Tzankov A, Pülzl P, Piza-Katzer H. Hypertrophic scars and keloids – a review of their pathophysiology, risk factors, and therapeutic management. Dermatologic Surg. 2009;35:171–181. doi:10.1111/j.1524-4725.2008.34406.x
- Gunathilake R, Schurer NY, Shoo BA, et al. pH-regulated mechanisms account for pigment-type differences in epidermal barrier function. J Invest Dermatol. 2009;129:1719–1729. doi:10.1038/jid.2008.442
- Alaluf S, Atkins D, Barrett K, et al. Ethnic variation in melanin content and composition in photoexposed and photoprotected human skin. Pigment Cell Res. 2002;15:112–118. doi:10.1034/j.1600-0749.2002.1o071.x
- Gao FL, Jin R, Zhang L, Zhang YG. The contribution of melanocytes to pathological scar formation during wound healing. Int J Clin Exp Med. 2013;6:609–613.
- Langton AK, Sherratt MJ, Sellers WI, et al. Geographical ancestry is a key determinant of epidermal morphology and dermal composition. Br J Dermatol. 2014;171:274–282. doi:10.1111/bjd.12860
- Woodley DT, Chen M. The basement membrane zone. In: Freinkel RK, Woodley DT, editors. The Biology of the Skin. Parthenon publishing; 2001:133–152.
- Girardeau-Hubert S, Pageon H, Asselineau D. In vivo and in vitro approaches in understanding the differences between Caucasian and African skin types: specific involvement of the papillary dermis. Int J Dermatol. 2012;51:1–4. doi:10.1111/j.1365-4632.2012.05553.x
- Lim IJ, Phan TT, Bay BH, et al. Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloid-like manner. Am J Physiol Cell Physiol. 2002;283:C212–C222. doi:10.1152/ajpcell.00555.2001
- Phan TT, Lim IJ, Bay BH, et al. Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro. Am J Physiol Cell Physiol. 2003;284:C860–C869. doi:10.1152/ajpcell.00350.2002
- Mikulec AA, Hanasono MM, Lum J, et al. Effect of tamoxifen on transforming growth factor β 1 production by keloid and fetal fibroblasts. Arch Facial Plast Surg. 2001;3:111–114. doi:10.1001/archfaci.3.2.111
- Xia W, Longaker MT, Yang GP. P38 MAP kinase mediates transforming growth factor-β2 transcription in human keloid fibroblasts. Am J Physiol Regul Integr Comp Physiol. 2005;290:R501–R508. doi:10.1152/ajpregu.00472.2005
- Ghazizadeh M, Tosa M, Shimizu H, et al. Functional implications of the IL-6 signaling pathway in keloid pathogenesis. J Invest Dermatol. 2007;127:98–105. doi:10.1038/sj.jid.5700564
- Do DV, Ong CT, Khoo YT, et al. Interleukin-18 system plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. Br J Dermatol. 2012;166:1275–1288. doi:10.1111/j.1365-2133.2011.10721.x
- Boyce DE, Ciampolini J, Ruge F, et al. Inflammatory cell subpopulations in keloid scars. Br J Plast Surg. 2001;54:511–516. doi:10.1054/bjps.2001.3638
- Ammendola M, Zuccalà V, Patruno R, et al. Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention. Updates Surg. 2013;65:53–57. doi:10.1007/s13304-012-0183-y
- Zawar VP, Agarwal M, Vasudevan B. Treatment of postinflammatory pigmentation due to acne with Q-switched neodymium-doped yttrium aluminum garnet in 78 Indian cases. J Cutan Aesthet Surg. 2015;8:222–226. doi:10.4103/0974-2077.172196
- Hakozaki T, Swanson CL, Bissett DL. Hyperpigmentation in aging skin. In: Farage M, Miller K, Maibach H, editors. Textbook of Aging Skin. Berlin, Heidelberg: Springer; 2017. doi:10.1007/978-3-662-47398-6_51
- Noh TK, Choi SJ, Chung BY, et al. Inflammatory features of melasma lesions in Asian skin. J Dermatol. 2014;41:788–794. doi:10.1111/1346-8138.12573
- Iriyama S, Ono T, Aoki H, Amano S. Hyperpigmentation in human solar lentigo is promoted by heparanase-induced loss of heparan sulfate chains at the dermal-epidermal junction. J Dermatol Sci. 2011;64:223–228. doi:10.1016/j.jdermsci.2011.09.007
- Hager K, Machein U, Krieger S, et al. Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging. 1994;15:771–772. doi:10.1016/0197-4580(94)90066-3
- Ballou SP, Lozanski FB, Hodder S, et al. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing. 1996;25:224–230. doi:10.1093/ageing/25.3.224
- Ershler WB, Sun WH, Binkley N, et al. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res. 1993;12:225–230.
- Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, et al. Chronic stress and age-related increases in the proinflammatory cytokine Il-6. Proc Natl Acad Sci U S A. 2003;100:9090–9095. doi:10.1073/pnas.1531903100
- Maggio M, Guralnik JM, Longo DL, Ferrucci L. Interleukin-6 in aging and chronic disease: a magnificent pathway. J Gerontol a Biol Sci Med Sci. 2006;61:575–584. doi:10.1093/gerona/61.6.575
- Ohtani N. The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis? Inflamm Regener. 2022;42:11. doi:10.1186/s41232-022-00197-8
- Ho CY, Dreesen O. Faces of cellular senescence in skin aging. Mech Ageing Dev. 2021;198:111525. doi:10.1016/j.mad.2021.111525
- Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression Annu Rev Pathol. 2010;5:99–118. doi:10.1146/annurev-pathol-121808-102144
- Fatima S, Braunberger T, Mohammad TF, et al. The role of sunscreen in melasma and postinflammatory hyperpigmentation. Indian J Dermatol. 2020;65:5–10. doi:10.4103/ijd.ijd_295_18
- Puaratanaarunkon T, Asawanonda P. A randomized, double blinded, split-face study of the efficacy of using a broad spectrum sunscreen with anti-inflammatory agent to reduce post inflammatory hyperpigmentation after picosecond laser. Clin Cosmet Investig Dermatol. 2022;15:331–337. doi:10.2147/CCID.S355329
- Ansary TM, Hossain MR, Kamiya K, et al. inflammatory molecules associated with ultraviolet radiation-mediated skin aging. Int J Mol Sci. 2021;22:3974. doi:10.3390/ijms22083974
- Wlaschek M, Maity P, Makrantonaki E, Scharffetter-Kochanek K. Connective tissue and fibroblast senescence in skin aging. J Investig Dermatol. 2021;141:985–992. doi:10.1016/j.jid.2020.11.010
- Ansel J, Perry P, Brown J, et al. Cytokine modulation of keratinocyte cytokines. J Investig Dermatol. 1990;94:s101–s107. doi:10.1111/1523-1747.ep12876053
- Yoon JE, Kim Y, Kwon S, et al. Senescent fibroblasts drive ageing pigmentation: a potential therapeutic target for senile lentigo. Theranostics. 2018;8:4620–4632. doi:10.7150/thno.26975
- Nikalji N, Godse K, Sakhiya J, et al. Complications of medium depth and deep chemical peels. J Cutan Aesthet Surg. 2012;5:254–260. doi:10.4103/0974-2077.104913
- Searle T, Al-Niaimi F, Ali FR. The top 10 cosmeceuticals for facial hyperpigmentation. Dermatol Ther. 2020;33:e14095. doi:10.1111/dth.14095
- Tan MG, Kim WB, Jo CE, et al. Topical treatment for postinflammatory hyperpigmentation: a systematic review. J Dermatolog Treat. 2022;33:2518–2526. doi:10.1080/09546634.2021.1981814
- Callender VD, Baldwin H, Cook-Bolden FE, et al. Effects of topical retinoids on acne and post-inflammatory hyperpigmentation in patients with skin of color: a clinical review and implications for practice. Am J Clin Dermatol. 2022;23:69–81. doi:10.1007/s40257-021-00643-2
- Mastrofrancesco A, Ottaviani M, Aspite N, et al. Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation. Exp Dermatol. 2010;19:813–820. doi:10.1111/j.1600-0625.2010.01107.x
- Saeedi M, Eslamifar M, Khezri K. Kojic acid applications in cosmetic and pharmaceutical preparations. Biomed Pharmacother. 2019;110:582–593. doi:10.1016/j.biopha.2018.12.006
- Gil TY, Hong CH, An HJ. Anti-inflammatory effects of ellagic acid on keratinocytes via MAPK and STAT pathways. Int J Mol Sci. 2021;22:1277. doi:10.3390/ijms22031277
- Aziz N, Kim MY, Cho JY. Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies. J Ethnopharmacol. 2018;225:342–358. doi:10.1016/j.jep.2018.05.019
- Mammone T, Gan D, Fthenakis C, Marenus K. The effect of N-acetyl-glucosamine on stratum corneum desquamation and water content in human skin. J Cosmet Sci. 2009;60:423–428.
- Shikhman AR, Kuhn K, Alaaeddine N, Lotz M. N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes. J Immunol. 2001;166:5155–5160. doi:10.4049/jimmunol.166.8.5155
- Shi X, Jie L, Wu P, et al. Calycosin mitigates chondrocyte inflammation and apoptosis by inhibiting the PI3K/AKT and NF-κB pathways. J Ethnopharmacol. 2022;297:115536. doi:10.1016/j.jep.2022.115536
- Park MY, Kwon HJ, Sung MK. Dietary aloin, aloesin, or aloe-gel exerts anti-inflammatory activity in a rat colitis model. Life Sci. 2011;88:486–492. doi:10.1016/j.lfs.2011.01.010
- Qiu Y, Yang X, Wang L, et al. L-arginine inhibited inflammatory response and oxidative stress induced by lipopolysaccharide via arginase-1 signaling in IPEC-J2 cells. Int J Mol Sci. 2019;20:1800. doi:10.3390/ijms20071800
- Shahinozzaman M, Ishii T, Halim MA, et al. Cytotoxic and anti-inflammatory resorcinol and alkylbenzoquinone derivatives from the leaves of Ardisia sieboldii. Z Naturforsch C J Biosci. 2019;74:303–311. doi:10.1515/znc-2019-0114
- Cheyasak N, Manuskiatti W, Maneeprasopchoke P, Wanitphakdeedecha R. Topical corticosteroids minimise the risk of postinflammatory hyper-pigmentation after ablative fractional CO2 laser resurfacing in Asians. Acta Derm Venereol. 2015;95:201–205. doi:10.2340/00015555-1899
- Nguyen AV, Soulika AM. The dynamics of the skin’s immune system. Int J Mol Sci. 2019;20:1811. doi:10.3390/ijms20081811
- Ho AW, Kupper TS. T cells and the skin: from protective immunity to inflammatory skin disorders. Nat Rev Immunol. 2019;19:490–502. doi:10.1038/s41577-019-0162-3